Acryl (0007C0.KQ) Osake Kurssi

Acryl Inc generates revenue through its AI application software products Jonathan and Nadia. Jonathan serves as an integrated AI platform supporting the entire AI adoption cycle, from data collection and refinement to processing for various AI models, targeting businesses seeking to implement AI solutions. Nadia provides medical information systems tailored for Korean hospitals and healthcare institutions in low- and middle-income countries, focusing on localized healthcare environments. The company's primary customers include businesses adopting AI technologies and healthcare providers in specific regional markets. The firm's revenue streams are derived from licensing Jonathan to enterprises requiring comprehensive AI integration tools and from deploying Nadia in healthcare settings where localized medical solutions are needed. Jonathan is positioned as a full-cycle AI solution provider, while Nadia addresses healthcare system optimization in both developed and emerging markets. Acryl Inc's business model centers on delivering specialized software products that solve specific industry challenges in AI and healthcare.